A guide to UK peptide legality

UK peptide regulation is more nuanced than the social-media version suggests. Most peptides discussed in performance and longevity contexts fall into one of three categories: licensed Prescription-Only Medicines (POM), unlicensed compounds with no UK marketing authorisation, or compounds approved overseas but unlicensed in the UK. Each category has different legal implications for supply, possession, and personal use.

This guide summarises the regulatory framework and the practical implications for UK readers. It is not legal advice — it's a clinician-reviewed reference document.

Prescription-only medicines (POM)

POMs are licensed by the MHRA (Medicines and Healthcare products Regulatory Agency) and can only be supplied legally in the UK with a valid prescription from a UK-registered prescriber. Tirzepatide, semaglutide, and liraglutide all fall into this category for their licensed indications.

Supply outside a prescription is illegal under the Human Medicines Regulations 2012 — both for the seller and, in some circumstances, for the buyer. The MHRA actively enforces against unlicensed online suppliers.

Unlicensed peptides — the "research chemical" category

Most peptides discussed in performance contexts (BPC-157, CJC-1295, Ipamorelin, TB-500, etc.) have no UK marketing authorisation. They are sold legally only as "research chemicals" — compounds intended for in-vitro research, not human use.

Selling these compounds for human use is illegal under the Human Medicines Regulations 2012. The "research chemical" framing exists to keep the seller within the law; once a buyer uses the compound on themselves, both parties have moved outside the legal framework, regardless of disclaimers.

Approved-overseas, unlicensed-in-UK

Some peptides are approved as prescription medicines in other countries but have no UK marketing authorisation. Semax is a clear example: it's a prescription medicine in Russia for ischaemic stroke, but unlicensed in the UK.

Compounds in this category are sometimes available on a "specials" basis or through compassionate-use frameworks — but for ordinary supply, the same constraints apply as for fully unlicensed peptides.

WADA (sport) implications

The World Anti-Doping Agency Prohibited List bans specific peptide categories at all times for competitive athletes — including all GLP-1 receptor agonists, all GH secretagogues (GHRPs and GHRH analogues), GH itself, and growth-factor modulators including TB-500.

For UK athletes registered with their national sport governing body, "I had a prescription" is not always a sufficient defence — Therapeutic Use Exemptions (TUE) must be applied for in advance for prohibited compounds, even where a clinical indication exists.

Personal use and possession

The legal status of personal possession (without supply) is more nuanced than the supply rules. POMs supplied with a valid prescription are entirely legal to possess. Unlicensed peptides imported for personal use are technically not regulated as controlled drugs, but importation can still trigger Border Force action under medicines legislation in some circumstances.

In practice, the enforcement focus is on suppliers, not personal-use possessors. But "rarely enforced" is not the same as "legal" — and individual circumstances can vary.